Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Share Price

Equities

600866

CNE000000H46

Food Processing

End-of-day quote Shanghai S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
5.04 CNY -0.98% Intraday chart for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong +20.86% +8.15%

Financials

Sales 2022 17.49B 2.41B 193B Sales 2023 17.37B 2.4B 192B Capitalization 7.74B 1.07B 85.57B
Net income 2022 608M 83.91M 6.72B Net income 2023 678M 93.57M 7.49B EV / Sales 2022 0.76 x
Net Debt 2022 3.45B 476M 38.1B Net Debt 2023 2.79B 384M 30.79B EV / Sales 2023 0.61 x
P/E ratio 2022
11.6 x
P/E ratio 2023
11.4 x
Employees 8,908
Yield 2022 *
-
Yield 2023
-
Free-Float 32.79%
More Fundamentals * Assessed data
Dynamic Chart
China stocks down, dragged by cyclical shares; HK shares up RE
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CJ Cheiljedang Files 20 Million Yuan Patent Case Against Star Lake Bioscience's Unit MT
Guangxin Bio-Intelligent Manufacturing Technology Innovation Co., Ltd. announced that it has received CNY 120 million in funding from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Guangdong Guangxin Innovation Research Institute Co., Ltd. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong cancelled the transaction announced on March 20, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong(XSSC:600866) added to S&P Global BMI Index CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Star Lake Bioscience to Raise $208 Million for Biotech Firm Purchase MT
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day-0.98%
1 week+20.86%
Current month+16.67%
1 month+15.86%
3 months+13.51%
6 months+0.40%
Current year+8.15%
More quotes
1 week
4.18
Extreme 4.18
5.34
1 month
3.81
Extreme 3.81
5.34
Current year
3.35
Extreme 3.35
5.34
1 year
3.35
Extreme 3.35
5.85
3 years
3.35
Extreme 3.35
9.34
5 years
3.35
Extreme 3.35
9.34
10 years
2.89
Extreme 2.89
9.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 23/09/19
Director of Finance/CFO 49 14/10/21
Director/Board Member 51 12/09/23
Members of the board TitleAgeSince
Director/Board Member 55 17/09/13
Director/Board Member 56 31/01/11
Director of Finance/CFO 48 13/02/20
More insiders
Date Price Change Volume
26/04/24 5.04 -0.98% 48,584,510
25/04/24 5.09 -1.74% 92,274,610
24/04/24 5.18 +8.14% 151,016,900
23/04/24 4.79 +10.11% 8,337,658
22/04/24 4.35 +4.32% 16,474,530

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
STAR LAKE BIOSCIENCE CO., INC. ZHAOQING GUANGDONG is a China-based company principally engaged in the bio-chemical and bio-fermentation business. The Company's principal products are biochemical drugs, feed additives and food additives, including nucleotide additives, amino acid feed additives, nucleoside and nucleotide bulk pharmaceutical chemicals (BPCs), as well as amino acid BPC and intermediates. The Company mainly sells its products in domestic and overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600866 Stock